Asper Biogene – genetic testing company

We can easily redesign our existing gene panels to match your clinical practice or research project.  Ask for personal solutions.

We have updated Parkinson’s disease NGS panel with two new genes. Del/dup analysis is also available.

.

Comprehensive Limb-Girdle Muscular Dystrophy test is now available. The new test enables detection of disease-causing variants by sequencing of a multigene panel and deletion/duplication analysis.

Del/dup analysis can now be ordered in addition to NGS panels.

Vitreoretinopathy NGS panel with 19 genes has been added to Asper Ophthalmics testing portfolio.

Bioinformatic analysis and interpretation of customer’s genetic data. Ask customized solution from our experienced team to facilitate your clinical practice.